While nontyphoidal Salmonella (NTS) has long been recognized as a cause of self-limited gastroenteritis, it is becoming increasingly evident that multiple-antibiotic-resistant strains are also emerging as important causes of invasive bacteremia and focal infections, resulting in hospitalizations and deaths. We have constructed attenuated Salmonella enterica serovar Typhimurium and Salmonella enterica serovar Enteritidis strains that can serve as live oral vaccines and as "reagent strains" for subunit vaccine production in a safe and economical manner. An unexpected consequence of systematic blood and body fluid (cerebrospinal fluid, etc.) culture-based surveillance for invasive bacterial infections in sub-Saharan Africa was the discovery that in infants and toddlers in multiple geographic sites, nontyphoidal Salmonella (NTS) infections rivaled Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae infections in their frequency and severity (7,8,23,32,35,39,43,46,51,60). Incidence rates of 200 to 350 cases of invasive NTS infections/10 5 infections in infants and toddlers were recorded, and it was found that the majority of invasive NTS strains were resistant to multiple clinically relevant antibiotics and had high case fatality rates (typically between 20 and 30%) (8,23,35,43).